Epstein Secrets

ashing ethical standards — of both formal and common sense varieties — before he was ever charged with a crime. A year before Collins was indicted, the Office of Congressional Ethics reported that it found "a substantial reason to believe" that Collins violated federal law by touting the stock of Innate Immunotherapeutics, an Au

ceutical distributors in the United States. Charges were also filed against Laurence F. Doud III, the company's former chief executive officer; and William Pietruszewski, the company's former chief compliance officer. The indictment was specifically for "unlawfully distributing oxycodone and fentanyl, and conspiring

ashing ethical standards — of both formal and common sense varieties — before he was ever charged with a crime. A year before Collins was indicted, the Office of Congressional Ethics reported that it found "a substantial reason to believe" that Collins violated federal law by touting the stock of Innate Immunotherapeutics, an Au

ceutical distributors in the United States. Charges were also filed against Laurence F. Doud III, the company's former chief executive officer; and William Pietruszewski, the company's former chief compliance officer. The indictment was specifically for "unlawfully distributing oxycodone and fentanyl, and conspiring

ashing ethical standards — of both formal and common sense varieties — before he was ever charged with a crime. A year before Collins was indicted, the Office of Congressional Ethics reported that it found "a substantial reason to believe" that Collins violated federal law by touting the stock of Innate Immunotherapeutics, an Au

ceutical distributors in the United States. Charges were also filed against Laurence F. Doud III, the company's former chief executive officer; and William Pietruszewski, the company's former chief compliance officer. The indictment was specifically for "unlawfully distributing oxycodone and fentanyl, and conspiring